Oncology Section EDGE Task Force on Urogenital Cancer: A Systematic Review of Clinical Measures for Incontinence

Alicia Jeffrey, Shana E. Harrington, Alexandra Hill, Amanda Roscow, Meryl Alappattu

Research output: Contribution to journalReview article

Abstract

Background: Compared with the general population, women and men with urogenital and colorectal cancers experience higher rates of urinary and fecal incontinence. Although a variety of measures exist to assess these areas, currently, there are no guidelines recommending which outcomes rehabilitation professionals should administer to examine these impairments in those with cancer. Purpose: To identify outcome measures for assessing urinary and fecal incontinence and evaluate their psychometric data and applicability to the cancer population. Methods: Multiple electronic databases (CINAHL, MEDLINE, PsycINFO) were reviewed using specific search terms to locate articles that identify outcome measures assessing urinary and fecal incontinence. As part of a larger effort to identify outcome measures for both incontinence and sexual dysfunction, 1118 articles were initially identified, 228 articles were reviewed, and 37 outcome measures were selected for analysis, 13 of which were related to urinary and fecal incontinence. Each incontinence outcome measure was independently reviewed and rated by 2 reviewers using the Cancer Evaluation Database to Guide Effectiveness (EDGE) Task Force Outcome Measure Rating Form. Any discrepancies between reviewers were discussed, and an overall recommendation for each outcome measure was made using the 4-point Cancer EDGE Task Force Rating Scale. Results: The Task Force was able to highly recommend 1 measure addressing urinary incontinence (American Urological Association Symptom Index) and 2 measures assessing urinary and fecal incontinence (Pelvic Floor Distress Inventory-Short Form, and Pelvic Floor Impact Questionnaire-Short Form). The Task Force also recommended 2 measures of urinary incontinence that demonstrated strong psychometric properties but had not yet been evaluated in the cancer population (Incontinence Quality-of-Life Questionnaire, International Consultation on Incontinence Questionnaire-Short Form). The Task Force was unable to recommend any measures that solely addressed fecal incontinence. Conclusions: Five of the 13 outcome measures assessing urinary incontinence and 2 of the 13 measures assessing urinary and fecal incontinence demonstrated satisfactory psychometric properties and application to the urogenital cancer population and are thereby recommended for use by the Task Force.

Original languageEnglish (US)
Pages (from-to)130-136
Number of pages7
JournalRehabilitation Oncology
Volume35
Issue number3
DOIs
StatePublished - Jul 1 2017
Externally publishedYes

Fingerprint

Urogenital Neoplasms
Urinary Incontinence
Advisory Committees
Fecal Incontinence
Databases
Outcome Assessment (Health Care)
Psychometrics
Pelvic Floor
Neoplasms
Population
MEDLINE
Colorectal Neoplasms
Referral and Consultation
Quality of Life
Guidelines

All Science Journal Classification (ASJC) codes

  • Physical Therapy, Sports Therapy and Rehabilitation
  • Rehabilitation
  • Oncology
  • Oncology(nursing)

Cite this

Oncology Section EDGE Task Force on Urogenital Cancer : A Systematic Review of Clinical Measures for Incontinence. / Jeffrey, Alicia; Harrington, Shana E.; Hill, Alexandra; Roscow, Amanda; Alappattu, Meryl.

In: Rehabilitation Oncology, Vol. 35, No. 3, 01.07.2017, p. 130-136.

Research output: Contribution to journalReview article

Jeffrey, Alicia ; Harrington, Shana E. ; Hill, Alexandra ; Roscow, Amanda ; Alappattu, Meryl. / Oncology Section EDGE Task Force on Urogenital Cancer : A Systematic Review of Clinical Measures for Incontinence. In: Rehabilitation Oncology. 2017 ; Vol. 35, No. 3. pp. 130-136.
@article{3b7c408c8bc143b48705fca08e2c1dca,
title = "Oncology Section EDGE Task Force on Urogenital Cancer: A Systematic Review of Clinical Measures for Incontinence",
abstract = "Background: Compared with the general population, women and men with urogenital and colorectal cancers experience higher rates of urinary and fecal incontinence. Although a variety of measures exist to assess these areas, currently, there are no guidelines recommending which outcomes rehabilitation professionals should administer to examine these impairments in those with cancer. Purpose: To identify outcome measures for assessing urinary and fecal incontinence and evaluate their psychometric data and applicability to the cancer population. Methods: Multiple electronic databases (CINAHL, MEDLINE, PsycINFO) were reviewed using specific search terms to locate articles that identify outcome measures assessing urinary and fecal incontinence. As part of a larger effort to identify outcome measures for both incontinence and sexual dysfunction, 1118 articles were initially identified, 228 articles were reviewed, and 37 outcome measures were selected for analysis, 13 of which were related to urinary and fecal incontinence. Each incontinence outcome measure was independently reviewed and rated by 2 reviewers using the Cancer Evaluation Database to Guide Effectiveness (EDGE) Task Force Outcome Measure Rating Form. Any discrepancies between reviewers were discussed, and an overall recommendation for each outcome measure was made using the 4-point Cancer EDGE Task Force Rating Scale. Results: The Task Force was able to highly recommend 1 measure addressing urinary incontinence (American Urological Association Symptom Index) and 2 measures assessing urinary and fecal incontinence (Pelvic Floor Distress Inventory-Short Form, and Pelvic Floor Impact Questionnaire-Short Form). The Task Force also recommended 2 measures of urinary incontinence that demonstrated strong psychometric properties but had not yet been evaluated in the cancer population (Incontinence Quality-of-Life Questionnaire, International Consultation on Incontinence Questionnaire-Short Form). The Task Force was unable to recommend any measures that solely addressed fecal incontinence. Conclusions: Five of the 13 outcome measures assessing urinary incontinence and 2 of the 13 measures assessing urinary and fecal incontinence demonstrated satisfactory psychometric properties and application to the urogenital cancer population and are thereby recommended for use by the Task Force.",
author = "Alicia Jeffrey and Harrington, {Shana E.} and Alexandra Hill and Amanda Roscow and Meryl Alappattu",
year = "2017",
month = "7",
day = "1",
doi = "10.1097/01.REO.0000000000000068",
language = "English (US)",
volume = "35",
pages = "130--136",
journal = "Rehabilitation Oncology",
issn = "2168-3808",
publisher = "American Physical Therapy Association",
number = "3",

}

TY - JOUR

T1 - Oncology Section EDGE Task Force on Urogenital Cancer

T2 - A Systematic Review of Clinical Measures for Incontinence

AU - Jeffrey, Alicia

AU - Harrington, Shana E.

AU - Hill, Alexandra

AU - Roscow, Amanda

AU - Alappattu, Meryl

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Background: Compared with the general population, women and men with urogenital and colorectal cancers experience higher rates of urinary and fecal incontinence. Although a variety of measures exist to assess these areas, currently, there are no guidelines recommending which outcomes rehabilitation professionals should administer to examine these impairments in those with cancer. Purpose: To identify outcome measures for assessing urinary and fecal incontinence and evaluate their psychometric data and applicability to the cancer population. Methods: Multiple electronic databases (CINAHL, MEDLINE, PsycINFO) were reviewed using specific search terms to locate articles that identify outcome measures assessing urinary and fecal incontinence. As part of a larger effort to identify outcome measures for both incontinence and sexual dysfunction, 1118 articles were initially identified, 228 articles were reviewed, and 37 outcome measures were selected for analysis, 13 of which were related to urinary and fecal incontinence. Each incontinence outcome measure was independently reviewed and rated by 2 reviewers using the Cancer Evaluation Database to Guide Effectiveness (EDGE) Task Force Outcome Measure Rating Form. Any discrepancies between reviewers were discussed, and an overall recommendation for each outcome measure was made using the 4-point Cancer EDGE Task Force Rating Scale. Results: The Task Force was able to highly recommend 1 measure addressing urinary incontinence (American Urological Association Symptom Index) and 2 measures assessing urinary and fecal incontinence (Pelvic Floor Distress Inventory-Short Form, and Pelvic Floor Impact Questionnaire-Short Form). The Task Force also recommended 2 measures of urinary incontinence that demonstrated strong psychometric properties but had not yet been evaluated in the cancer population (Incontinence Quality-of-Life Questionnaire, International Consultation on Incontinence Questionnaire-Short Form). The Task Force was unable to recommend any measures that solely addressed fecal incontinence. Conclusions: Five of the 13 outcome measures assessing urinary incontinence and 2 of the 13 measures assessing urinary and fecal incontinence demonstrated satisfactory psychometric properties and application to the urogenital cancer population and are thereby recommended for use by the Task Force.

AB - Background: Compared with the general population, women and men with urogenital and colorectal cancers experience higher rates of urinary and fecal incontinence. Although a variety of measures exist to assess these areas, currently, there are no guidelines recommending which outcomes rehabilitation professionals should administer to examine these impairments in those with cancer. Purpose: To identify outcome measures for assessing urinary and fecal incontinence and evaluate their psychometric data and applicability to the cancer population. Methods: Multiple electronic databases (CINAHL, MEDLINE, PsycINFO) were reviewed using specific search terms to locate articles that identify outcome measures assessing urinary and fecal incontinence. As part of a larger effort to identify outcome measures for both incontinence and sexual dysfunction, 1118 articles were initially identified, 228 articles were reviewed, and 37 outcome measures were selected for analysis, 13 of which were related to urinary and fecal incontinence. Each incontinence outcome measure was independently reviewed and rated by 2 reviewers using the Cancer Evaluation Database to Guide Effectiveness (EDGE) Task Force Outcome Measure Rating Form. Any discrepancies between reviewers were discussed, and an overall recommendation for each outcome measure was made using the 4-point Cancer EDGE Task Force Rating Scale. Results: The Task Force was able to highly recommend 1 measure addressing urinary incontinence (American Urological Association Symptom Index) and 2 measures assessing urinary and fecal incontinence (Pelvic Floor Distress Inventory-Short Form, and Pelvic Floor Impact Questionnaire-Short Form). The Task Force also recommended 2 measures of urinary incontinence that demonstrated strong psychometric properties but had not yet been evaluated in the cancer population (Incontinence Quality-of-Life Questionnaire, International Consultation on Incontinence Questionnaire-Short Form). The Task Force was unable to recommend any measures that solely addressed fecal incontinence. Conclusions: Five of the 13 outcome measures assessing urinary incontinence and 2 of the 13 measures assessing urinary and fecal incontinence demonstrated satisfactory psychometric properties and application to the urogenital cancer population and are thereby recommended for use by the Task Force.

UR - http://www.scopus.com/inward/record.url?scp=85021795204&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021795204&partnerID=8YFLogxK

U2 - 10.1097/01.REO.0000000000000068

DO - 10.1097/01.REO.0000000000000068

M3 - Review article

AN - SCOPUS:85021795204

VL - 35

SP - 130

EP - 136

JO - Rehabilitation Oncology

JF - Rehabilitation Oncology

SN - 2168-3808

IS - 3

ER -